Supplementary tests are generally considered in the following scenarios:
When routine H&E staining is inconclusive. To differentiate between neoplastic and non-neoplastic lesions. To identify specific types of cancer and their subtypes. For the detection of infectious agents that are not easily visible with standard stains. To determine the molecular profile of a tumor, which can guide targeted therapy.
